Cenci Nilsson heads the Basal Ganglia Pathophysiology Laboratory at Lund University.
The laboratory is part of three centres of excellence in translational neuroscience supported by the Swedish National Research Council ( BAGADILICO, www.med.lu.se/bagadilico; the Neuronano Research Centre, www.med.lu.se/nrc; and Multipark, www.med.lu.se/multipark). The laboratory was also part of the finished project Neurofortis, www.med.lu.se/neurofortis.
Current research activities in this laboratory are directed towards discovering new symptomatic and neurorestorative/neuroprotective treatments for Parkinson's disease. In addition, the laboratory pursues basic scientific questions on the molecular and cellular alterations affecting the brain’s basal ganglia in Parkinson’s disease and in hyperkinetic movement disorders (i.e. L-DOPA-induced dyskinesia, graft-induced dyskinesia, and dystonia).
Angela Cenci Nilsson (M. A. Cenci in all published papers) obtained a Medical Degree and a clinical specialization in Neurology at the University of Verona (Italy).
Her clinical education was followed by a PhD degree in Neurobiology at Lund University under the supervision of Prof. Anders Björklund (1993). At Lund University, Cenci Nilsson received appointments as Assistant Professor of Neurobiology (1993-2002), Associate Professor of Neuroscience (2002-2008), and Professor of Experimental Medical Science (from 2008). Cenci Nilsson has pioneered the development of symptomatic models of parkinsonism and L-DOPA-induced dyskinesia in rodents, and has used these models to discover novel mechanisms of disease and new therapeutic approaches. For this research, Cenci Nilsson received the Erik K. Fernström Award for Young Promising Investigators (2003), and the Medal of Honours for Parkinson´s Research by the Swedish Parkinson’s Disease Foundation (2006).
Since 2005, Cenci Nilsson heads the Basal Ganglia Pathophysiology Unit at Lund University. The laboratory is part of four centres of excellence in translational neuroscience supported by the Swedish National Research Council (Neurofortis, www.med.lu.se/neurofortis; Multipark; BAGADILICO, www.med.lu.se/bagadilico; and the Neuronano Research Centre, www.med.lu.se/nrc).
Cenci Nilsson currently serves on the scientific advisory boards and steering committees of several national and international research organizations, including the Swedish Movement Disorder Society (from 2003); the International Basal Ganglia Society (2004-2010); NECTAR (Network of European CNS Transplantation and Restoration) (from 2005); The Swedish Parkinson’s Disease Foundation (2006-2009); The Swedish National Research Council (from 2006); The European Specialist Education Programme for Continuous Dopamine Stimulation in Parkinson’s Disease (from 2008); The International Movement Disorders Society Award Committee (from 2009), and The M.J. Fox Foundation for Parkinson’s Research (from 2010).